(Q43481126)

23 November 2017

title

Molecular analysis of the effect of topical imiquimod treatment of HPV 2/27/57-induced common warts (English)

1 reference

23 November 2017

S Jacobs

1

1 reference

23 November 2017

E-I Grussendorf-Conen

series ordinal

2

1 reference

23 November 2017

I Rösener

series ordinal

3

1 reference

23 November 2017

A Rübben

series ordinal

4

1 reference

23 November 2017

publication date

1 September 2004

1 reference

Skin Pharmacology and Physiology

23 November 2017

published in

1 reference

23 November 2017

volume

17

1 reference

23 November 2017

issue

5

1 reference

23 November 2017

page(s)

258-266

1 reference

Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms

23 November 2017

cites work

1 reference

The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR.

21 January 2018

1 reference

Clinical features and age distribution of patients with HPV 2/27/57-induced common warts

21 January 2018

1 reference

Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts

21 January 2018

1 reference

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

21 January 2018

1 reference

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

21 January 2018

1 reference

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

21 January 2018

1 reference

Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities

21 January 2018

1 reference

Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes

21 January 2018

1 reference

Immunological events in regressing genital warts

21 January 2018

1 reference

SNP genotyping on a genome-wide amplified DOP-PCR template

21 January 2018

1 reference

Recognition of microbial infection by Toll-like receptors

21 January 2018

1 reference

Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi.

21 January 2018

1 reference

Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.

21 January 2018

1 reference

Cytokines and chemokines in the epidermis

21 January 2018

1 reference

Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing

21 January 2018

1 reference

Notch/RBP-J signaling regulates epidermis/hair fate determination of hair follicular stem cells.

21 January 2018

1 reference

Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation

21 January 2018

1 reference

Characterization of mouse Frizzled-3 expression in hair follicle development and identification of the human homolog in keratinocytes

21 January 2018

1 reference

Structure-function relationship between the human chemokine receptor CXCR3 and its ligands

21 January 2018

1 reference

Regulation of macrophage activation

21 January 2018

1 reference

Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier (Imiquimod) in genital warts

21 January 2018

1 reference

Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth

21 January 2018

1 reference

Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma

21 January 2018

1 reference

The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000080219

1 reference

23 November 2017

1 reference